Senior Director, Market Access Operations, Europe
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Senior Director, European Market Access Operations acts as a strategic and operational partner to the Vice President, Value, Market Access and Pricing, Europe. The role provides leadership across the execution and delivery of key Market Access and launch-readiness priorities throughout the region.
As the central integrator for European Market Access, the role ensures that strategic priorities are translated into coordinated execution across functions, assets and markets. The Senior Director driv
